{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:23:50Z","timestamp":1780449830585,"version":"3.54.1"},"reference-count":112,"publisher":"SAGE Publications","issue":"15-16","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Human Gene Therapy"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:p>Regulators and industry are actively seeking improvements and alternatives to current models and approaches to evaluate potential carcinogenicity of gene therapies (GTs). A meeting of invited experts was organized by NC3Rs\/UKEMS (London, March 2023) to discuss this topic. This article describes the consensus reached among delegates on the definition of vector genotoxicity, sources of uncertainty, suitable toxicological endpoints for genotoxic assessment of GTs, and future research needs. The collected recommendations should inform the further development of regulatory guidelines for the nonclinical toxicological assessment of GT products.<\/jats:p>","DOI":"10.1089\/hum.2024.033","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T04:13:45Z","timestamp":1721880825000},"page":"527-542","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article"],"prefix":"10.1177","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6387-0192","authenticated-orcid":false,"given":"Jan C.","family":"Klapwijk","sequence":"first","affiliation":[{"name":"Cornelis Consulting Ltd, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Del Rio Espinola","sequence":"additional","affiliation":[{"name":"GentiBio Inc., Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Libertini","sequence":"additional","affiliation":[{"name":"Novartis Biomedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Collin","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mick D.","family":"Fellows","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Jobling","sequence":"additional","affiliation":[{"name":"TestaVec Ltd, Maidenhead, United Kingdom"},{"name":"Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Lynch","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Genetic Toxicology, Ware, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HansJoerg","family":"Martus","sequence":"additional","affiliation":[{"name":"Novartis Biomedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1642-5590","authenticated-orcid":false,"given":"Catherine","family":"Vickers","sequence":"additional","affiliation":[{"name":"National Centre for the Replacement Refinement and Reduction of Animals in Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zeller","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd., pRED, Pharma Research &amp; Early Development, Roche Innovation Center Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Biasco","sequence":"additional","affiliation":[{"name":"UCL Zayed Centre for Research (ZCR), London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn H.","family":"Brugman","sequence":"additional","affiliation":[{"name":"Cell and Gene Therapy, GSK Medicine Research Centre, Stevenage, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic D.","family":"Bushmann","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-4630","authenticated-orcid":false,"given":"Toni","family":"Cathomen","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine and Gene Therapy, Medical Center- University of Freiburg, Freiburg, Germany"},{"name":"Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9795-5206","authenticated-orcid":false,"given":"Hildegrund C.J.","family":"Ertl","sequence":"additional","affiliation":[{"name":"Ertl Laboratory, Vaccine &amp; Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gabriel","sequence":"additional","affiliation":[{"name":"ProtaGene CGT, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[{"name":"Horae Gene Therapy Center, UMass Chan Medical School, University of Massachusetts, Worcester, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Jadlowsky","sequence":"additional","affiliation":[{"name":"Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Kimber","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Lanz","sequence":"additional","affiliation":[{"name":"Drug Safety Research &amp; Development, Pfizer, Inc., Groton, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Levine","sequence":"additional","affiliation":[{"name":"Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth P.","family":"Micklethwaite","sequence":"additional","affiliation":[{"name":"Department of Haematology, Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, Australia"},{"name":"NSW Health Pathology Blood Transplant and Cell Therapies Laboratory \u2013 ICPMR Westmead, Sydney, Australia"},{"name":"Westmead Institute for Medical Research, Sydney, Australia"},{"name":"Sydney Medical School, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Onodera","sequence":"additional","affiliation":[{"name":"Gene &amp; Cell Therapy Promotion Center, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella M.","family":"Pizzurro","sequence":"additional","affiliation":[{"name":"Merck &amp; Co., Inc., Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Reed","sequence":"additional","affiliation":[{"name":"Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rothe","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise E.","family":"Sabatino","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA"},{"name":"The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse J.","family":"Salk","sequence":"additional","affiliation":[{"name":"Department of Medicine, Divisions of Hematology and Medical Oncology, University of Washington School of Medicine, Seattle, Washington, USA"},{"name":"TwinStrand Biosciences Inc., Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2743-0070","authenticated-orcid":false,"given":"Axel","family":"Schambach","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany"},{"name":"Division of Hematology\/Oncology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Themis","sequence":"additional","affiliation":[{"name":"TestaVec Ltd, Maidenhead, United Kingdom"},{"name":"Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[{"name":"Kymera Therapeutics, Watertown, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00487-6"},{"key":"e_1_3_6_3_2","unstructured":"FDA. 2013. Preclinical Assessment of Investigational Cellular and Gene Therapy Products. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/biologics-guidances\/cellular-gene-therapy-guidances."},{"key":"e_1_3_6_4_2","unstructured":"FDA. 2020. Long Term Follow-Up After Administration of Human Gene Therapy Products. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/biologics-guidances\/cellular-gene-therapy-guidances."},{"key":"e_1_3_6_5_2","unstructured":"FDA. 2022. Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/biologics-guidances\/cellular-gene-therapy-guidances."},{"key":"e_1_3_6_6_2","unstructured":"EMA. 2008. Guideline on the non-clinical studies required before first clinical use of gene therapy medicinal products. EMEA\/CHMP\/GTWP\/125459\/2006."},{"key":"e_1_3_6_7_2","unstructured":"EMA. 2021. Guideline on quality non-clinical and clinical aspects of medicinal products containing genetically modified cells. EMA\/CAT\/GTWP\/671639\/2008 Rev. 1 \u2013 corr."},{"key":"e_1_3_6_8_2","unstructured":"MHLW. 2019. Ensuring the quality and safety of gene therapy products (draft). PSEHB\/MDED Notification No.0709-2. Available from: www.pmda.go.jp\/files\/000235607.pdf."},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007280"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2015.137"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci35798"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.232"},{"key":"e_1_3_6_13_2","unstructured":"Skysona: Summary Basis of Regulatory Action. 2022. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/skysona."},{"key":"e_1_3_6_14_2","unstructured":"Strimvelis: EPAR\u2014Product Information. Available from: https:\/\/www.ema.europa.eu\/documents\/product-information\/strimvelis-epar-product-information_en.pdf."},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021010813"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021010858"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2400209"},{"key":"e_1_3_6_18_2","unstructured":"FDA. 2024. Safety and Availability Communications: Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/2024-safety-and-availability-communications."},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178806"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02767-w"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068893"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci37630"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1142658"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0741-7"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.2174\/1566523215666150929110424"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1525-0016(03)00212-0"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.09.004"},{"key":"e_1_3_6_28_2","unstructured":"Strimvelis: EPAR\u2014Risk Management Plan Summary. Available from: www.ema.europa.eu\/documents\/rmp-summary\/strimvelis-epar-risk-management-plan-summary_en.pdf."},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190607"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.01.023"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.51"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09328"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31344-x"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/bf00120216"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)80436-5"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac092"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1305987110"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.639125"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci79213"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","unstructured":"Chen X Xie Q Liu H et al. Mol Ther 2024; 32(4):17\u201318; doi: 10.1016\/j.ymthe.2024.04.020 Promoter influences acute liver toxicity and long-term hepatic genotoxicity in rAAV SMA gene therapy in mice (ASGCT 27th Annual Meeting Abstracts).","DOI":"10.1016\/j.ymthe.2024.04.020"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.10.018"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2012.112"},{"key":"e_1_3_6_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022589"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7020-2791-8.50013-7"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2023.101159"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.06.004"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2023.134"},{"key":"e_1_3_6_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2023.04.009"},{"key":"e_1_3_6_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-021-00017-7"},{"key":"e_1_3_6_50_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009876"},{"key":"e_1_3_6_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.08.013"},{"key":"e_1_3_6_52_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2015.29014.kib"},{"key":"e_1_3_6_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3389"},{"key":"e_1_3_6_54_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318281"},{"key":"e_1_3_6_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3893"},{"key":"e_1_3_6_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.09.030"},{"key":"e_1_3_6_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113711"},{"key":"e_1_3_6_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26204"},{"key":"e_1_3_6_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2017.10.002"},{"key":"e_1_3_6_60_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603635103"},{"key":"e_1_3_6_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.3"},{"key":"e_1_3_6_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1216"},{"key":"e_1_3_6_63_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-024976"},{"key":"e_1_3_6_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.5"},{"key":"e_1_3_6_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.06.017"},{"key":"e_1_3_6_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.55"},{"key":"e_1_3_6_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01865-08"},{"key":"e_1_3_6_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1525-0016(16)36152-4"},{"key":"e_1_3_6_69_2","unstructured":"Themis M et al. under review. Available from: www.researchsquare.com\/article\/rs-3837253\/v1."},{"key":"e_1_3_6_70_2","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008171109981"},{"key":"e_1_3_6_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2021.09.004"},{"key":"e_1_3_6_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2021.07.004"},{"key":"e_1_3_6_73_2","doi-asserted-by":"publisher","DOI":"10.3390\/v15030698"},{"key":"e_1_3_6_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01974-7"},{"key":"e_1_3_6_75_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03729-5"},{"key":"e_1_3_6_76_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112712"},{"key":"e_1_3_6_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1380"},{"key":"e_1_3_6_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13915"},{"key":"e_1_3_6_79_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0702-735"},{"key":"e_1_3_6_80_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.52"},{"key":"e_1_3_6_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2021.09.005"},{"key":"e_1_3_6_82_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0648-4"},{"key":"e_1_3_6_83_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0178-z"},{"key":"e_1_3_6_84_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000219"},{"key":"e_1_3_6_85_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-17-1097"},{"key":"e_1_3_6_86_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1117032109"},{"key":"e_1_3_6_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth1103"},{"key":"e_1_3_6_88_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2057"},{"key":"e_1_3_6_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2016.11.002"},{"key":"e_1_3_6_90_2","doi-asserted-by":"publisher","DOI":"10.1089\/104303401750148649"},{"key":"e_1_3_6_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2020.10.012"},{"key":"e_1_3_6_92_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-020-6655-4"},{"key":"e_1_3_6_93_2","doi-asserted-by":"publisher","DOI":"10.2144\/btn-2023-0013"},{"key":"e_1_3_6_94_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01356-14"},{"key":"e_1_3_6_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.01.004"},{"key":"e_1_3_6_96_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02778-9"},{"key":"e_1_3_6_97_2","unstructured":"WHO International Standard. WHO 1st Reference Reagent for Lentiviral Vector Integration Site Analysis; NIBSC code: 18\/144 Instructions for use (Version 3.0 Dated 30\/09\/2020). Available from: www.nibsc.org\/documents\/ifu\/18-144.pdf."},{"key":"e_1_3_6_98_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200307010-00004"},{"key":"e_1_3_6_99_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01478-22"},{"key":"e_1_3_6_100_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.10.7951-7959.1997"},{"key":"e_1_3_6_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81587-1"},{"key":"e_1_3_6_102_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3866"},{"key":"e_1_3_6_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.042"},{"key":"e_1_3_6_104_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28762-2"},{"key":"e_1_3_6_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2013.08.011"},{"key":"e_1_3_6_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2020.04.016"},{"key":"e_1_3_6_107_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31292-6"},{"key":"e_1_3_6_108_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01389-4"},{"key":"e_1_3_6_109_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260825"},{"key":"e_1_3_6_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(05)82002-5"},{"key":"e_1_3_6_111_2","doi-asserted-by":"publisher","DOI":"10.1177\/1535370219898141"},{"key":"e_1_3_6_112_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1498"},{"key":"e_1_3_6_113_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33093-3"}],"container-title":["Human Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/hum.2024.033","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/hum.2024.033","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/hum.2024.033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:57:04Z","timestamp":1777449424000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/hum.2024.033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":112,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1089\/hum.2024.033"],"URL":"https:\/\/doi.org\/10.1089\/hum.2024.033","relation":{},"ISSN":["1043-0342","1557-7422"],"issn-type":[{"value":"1043-0342","type":"print"},{"value":"1557-7422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}